Jenburkt Pharmaceuticals Ltd Q1FY24 PAT lower at Rs. 5.36 crore

JENBURKT PHARMACEUTICALS LTD. has reported Standalone financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 30.2124 crores during the period ended June 30, 2023 as compared to Rs. 36.4548 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 5.3691 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 6.3539 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 12.17 for the period ended June 30, 2023 as compared to Rs. 13.92 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 30.2124 crs	₹36.4548 crs	-17.12%
Net Profit	₹5.3691 crs	₹6.3539 crs	-15.50%
EPS	₹12.17	₹13.92	-12.57%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 30.2124 crores during the period ended June 30, 2023 as compared to Rs.32.2745 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.5.3691 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.5.9532 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.12.17 for the period ended June 30, 2023 as compared to Rs.12.97 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 30.2124 crs	₹32.2745 crs	-6.39%
Net Profit	₹5.3691 crs	₹5.9532 crs	-9.81%
EPS	₹12.17	₹12.97	-6.17%

Shares of JENBURKT PHARMACEUTICALS LTD. was last trading in BSE at Rs. 762.05 as compared to the previous close of Rs. 756.80. The total number of shares traded during the day was 3987 in over 232 trades.

The stock hit an intraday high of Rs. 768.00 and intraday low of 752.60. The net turnover during the day was Rs. 3044527.00.

Source : Equity Bulls

Keywords

JenburktPharmaceuticals Q1FY24 ResultUpdate